Evidence map›Paper›PMID 36698942›Full record

ArticleFrontiers in cardiovascular medicine2022

Single-cell transcriptome

Shiyong Wu, Shibiao Liu, Baoheng Wang, Meng Li, Chao Cheng, Hairong Zhang, Ningheng Chen, Xueli Guo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Integrating single-cell RNA-seq datasets with substantial batch effects.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shiyong WuDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Shibiao LiuDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Baoheng WangDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Meng LiDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Chao ChengCenter for Genome Analysis, Wuhan Ruixing Biotechnology Co., Ltd., Wuhan, China.
Hairong ZhangDepartment of Colorectal and Anal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ningheng ChenDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xueli GuoDepartment of Vascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abdominal aortic aneurysm (AAA) is a life-threatening disease and there is currently a lack of effective treatment to prevent it rupturing. ScRNA-seq studies of AAA are still lacking. In the study, we analyzed the published AAA scRNA-seq datasets from the mouse elastase-induced model, CaCl

Indexed as

abdominal aortic aneurysmin silico analysismacrophages/monocytessingle-cell RNA sequencingsingle-cell transcriptome analysis

Identifiers

PMID36698942
PMCPMC9868255
OpenAlexW4313824118

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.